Send the following on WhatsApp
Continue to Chat多發性骨髓瘤 CAR-T 療法 Carvykti,一個月內相繼獲 FDA、EMA 核准 https://geneonline.news/car-t-carvykti-ema-approval/?variant=zh-cn
多發性骨髓瘤 CAR-T 療法 Carvykti,一個月內相繼獲 FDA、EMA 核准 https://geneonline.news/car-t-carvykti-ema-approval/?variant=zh-cn